Study period 1/1/2017 to 7/1/2025 Study population: inclusion Patients with A GLP-1 prescription for at least 90 days At least five pounds of weight loss while on the GLP-1 A weight reading between 30 days prior through 3 days after starting the GLP-1 A weight reading within 30 days of stopping the GLP-1 At least one weight reading 1 to 24 months following end of the GLP-1 Study population: exclusion Thyroid conditions (ever): ICD-10-CM E03*or E05* Eating disorders (ever): ICD-10-CM F50* Pregnancy within a year before GLP-1 start through GLP-1 stop Censoring Other weight loss medication or restart of GLP-1 Amputation Bariatric surgery Pregnancy that started in period after GLP-1 was stopped Outcomes Percent of weight change relative to initial weight loss after end of GLP-1 treatment GLP-1 A medication with a simple generic of semaglutide, liraglutide, or tirzepatide
EClinicalMedicine 40 , 101125 (2021)
10.1111/jdi.13932 17 ChristensenM.BaggerJ
A small, three amino acid (glycine-histidine-lysine or GHK) peptide that is famous for being a type I collagen fragment
Our process is part of a larger quality-control system that includes supplier accountability, product-level review, internal QA, professional storage, and direct in-house fulfillment
Wellness circles have discussed its potential role in promoting gut lining integrity, especially in individuals affected by high stress, poor diet, or lifestyle imbalances